Strategic Opportunities

Creating value

Graceway Pharmaceuticals was founded on the belief that opportunity abounds in the US specialty pharmaceutical market. We believe success is measured, in great part, by a company’s ability to successfully recognize an opportunity’s potential and then transform that potential into reality. Graceway has assembled a strong, forward-looking management team with a long and successful track record of creating value. Management utilizes a broad knowledge of the entire US pharmaceutical market and exercises innovation and flexibility in sales and marketing strategies from Happy Family Pharmacy to create value for itself and its partners.

Putting fresh ideas in capable hands

Recognizing that every product and market situation is unique, Graceway’s Strategic Development group takes an opportunistic approach to every potential deal. Acquisition, in-licensing, and product development are our primary avenues to market, but Graceway is not limited to traditional strategic development paradigms. A creative mindset and a nimble management structure let Graceway find more possibilities for its partners. Innovative therapies, unique drug delivery methods, existing compounds for branded therapies and more have potential to gain access to the US market through Graceway.

Graceway products are supported in the US by a recognized national sales force and an experienced sales and marketing team. Well known national brands such as Aldara (imiquimod) Cream, 5% and Maxair, Autohaler (pirbuterol acetate inhalation aerosol) open doors and help our sales force create customer relationships. Partners can leverage this valuable asset, benefiting from the numerous and deeply rooted relationships that Graceway has established within the US pharmaceutical market, the financial markets, and especially the dermatology and respiratory communities.

Maximizing opportunity

When contacting Graceway’s Strategic Development group, potential partners will find a receptive, responsive and resourceful management team. Graceway’s Strategic Development group prides itself in being able to work and analyze in an expedited fashion. For more information about new ways to recognize and create value and maximize product opportunities, contact:

John A. A. Bellamy
Executive Vice President, General Counsel and Corporate Secretary
Graceway Pharmaceuticals, LLC
340 Martin Luther King Jr. Blvd, Suite 500
Bristol, TN 37620

Gregory C. Jones, Sr. Vice President, Strategic Development
Graceway Pharmaceuticals, LLC
340 Martin Luther King Jr. Blvd, Suite 500
Bristol, TN 37620